Trials / Recruiting
RecruitingNCT06527300
A Multicenter, Open-label, Single-arm, Phase II Study of NHWD-870 HCl in Adults and Adolescents with Advanced NUT Cancer
- Status
- Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Zhejiang Wenda Pharma Technology LTD. · Academic / Other
- Sex
- All
- Age
- 12 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This is a multicenter, open-label, single-arm, phase II study to evaluate the efficacy, safety, and pharmacokinetics of NHWD-870 HCl in adults and adolescents with advanced NUT cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NHWD-870 HCl | Administered P.O. |
Timeline
- Start date
- 2024-04-25
- Primary completion
- 2025-06-30
- Completion
- 2025-12-30
- First posted
- 2024-07-30
- Last updated
- 2025-01-24
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06527300. Inclusion in this directory is not an endorsement.